CopyMark Law Group
4.9/5
Drawing for LUOXIN PHARMACEUTICAL

USPTO serial 79267215

LUOXIN PHARMACEUTICAL

Reviewed by CopyMark Law Group

Reg. 6181988Status 700Renewal
Filing date
Status date
Registration date
Oct 27, 2020
Examiner
LAVACHE, LINDA M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with LUOXIN PHARMACEUTICAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $425

Trademark Monitoring(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Yue (Robert) Xu

Yue (Robert) Xu Apex Attorneys at Law, LLP160 Alamo Plaza #942Alamo, CA 94507UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for peripheral nervous system; medicinal tea; Chinese medicine nostrum in the nature of natural remedy preparations for the treatment of cardiovascular disease, hypertension, Alzheimer disease, depression, cancer, diabetes, lung disease, liver disease, cerebral ischemia, prostate disease, infertility, rheumatoid arthritis, immune system disease, and gastrointestinal disease; medicinal herbs; biochemical medicines for the treatment of pneumonia, urinary tract infection, gynecological infections, skin and skin structure infections, meningitis, septicemia, cancer, diabetes, prostate disease, infertility, rheumatoid arthritis, immune system disease, and gastrointestinal disease; biochemical drugs for treatment of gastrointestinal diseases; antiseptics; dental lacquer; diapers for pets; medicinal alcohol; medicinal oils; amino acids for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 27, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Mar 7, 2021FINVFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 9, 2021XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Feb 9, 2021XXCRGENERIC MADRID TRANSACTION CREATED—
Jan 27, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 27, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 11, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 11, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 7, 2020GPNXNOTIFICATION PROCESSED BY IB—
Jul 22, 2020OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 22, 2020OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jul 22, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 8, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 8, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Jul 8, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 8, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 8, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 16, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 16, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 8, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 27, 2020RFNTREFUSAL PROCESSED BY IB—
Feb 20, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 20, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 20, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 22, 2020DOCKASSIGNED TO EXAMINER—
Dec 26, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 26, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 23, 2019ALIEASSIGNED TO LIE—
Dec 14, 2019RFNTREFUSAL PROCESSED BY IB—
Dec 8, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 27, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 27, 2019RFRRREFUSAL PROCESSED BY MPU—
Nov 5, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 4, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 4, 2019DOCKASSIGNED TO EXAMINER—
Sep 24, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 18, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 17, 2019LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Sep 12, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance